Shared Decision Making and Patient Engagement Program During AECOPD Hospitalization
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COPD Exacerbation
- Sponsor
- Universidad de Granada
- Enrollment
- 42
- Primary Endpoint
- Health related quality of life
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Patients require good communication with the physician to improve control illness. Shared decision making is a promising opportunity for chronic disease management due to the relative cost, medicine optimization and decreases hospital admissions/re-admissions
Detailed Description
Chronic obstructive pulmonary disease (COPD) is the leading one on hospital care cost, physician services, and prescription drugs. Additionally to the disease progression with the reduction in lung function, COPD patients experiment a progressive decline in functional capacity and health-related quality of life (HRQoL) with a significant burden in terms of disability. Shared Decision Making is defined as an approach where clinicians and patients share the available information to making clinical decisions, and where patients are counseled. SDM is a way to empower patients when decisions are made about treatment as a determinant factor in patient-centered care. Decision aids have been proven effective in improving disease knowledge, decision making, and self-care.
Investigators
Marie Carmen Valenza
Principal Investigator
Universidad de Granada
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria were COPD patients hospitalized due to acute exacerbation
Exclusion Criteria
- •Exclusion criteria were the inability to provide informed consent, the presence of psychiatric or cognitive disorders, progressive neurological disorders, organ failure, cancer, or inability to cooperate. Patients who had experienced another exacerbation of COPD in the previous month were also excluded.
Outcomes
Primary Outcomes
Health related quality of life
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
European Quality of Life questionnaire consists of the EQ-5D visual analog scale and the EQ-5D index. The visual analog scale has a rating scale of 0-100 (0 worst possible health, and 100 best possible health). The questionnaire has 5 domains: mobility, self-care, usual activity, pain, and anxiety-depression. For each item, the subject selects one of 3 descriptive health states (from good to poor).
Secondary Outcomes
- Physical activity(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Nutritional status(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Functional capacity associated with breathlessness(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- COPD Knowledge(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Adherence of inhalers(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)
- Functional capacity(Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up)